Learn from desmoid tumor experts to get the latest insights on this unique and rare disease.
Before making a treatment decision, consider consulting with a desmoid tumor expert
The websites listed above provide additional information if you are interested in submitting your patient cases to SARC or DTRF to be considered for review by a tumor board with desmoid tumor expertise.
The SARC Tumor Board and DTRF Virtual Tumor Board are independent of SpringWorks Therapeutics, Inc. Inclusion of these resources does not represent an endorsement or recommendation from SpringWorks Therapeutics for any group or organization. SpringWorks Therapeutics has no control over whether any case will be considered for review by a tumor board.
Location-specific ICD-10-CM codes for desmoid tumors went into effect on October 1, 2023.2 These diagnosis codes can be incorporated into your clinical practice.
Sign up for information
ICD-10-CM, International Classification of Diseases, Tenth Revision, Clinical Modification.
- Kasper B, Baumgarten C, Garcia J, et al. Desmoid Working Group. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma Patients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol. 2017;28(10):2399-2408.
- Centers for Medicare & Medicaid Services 2024 ICD-10-CM codes. Centers for Medicare & Medicaid Services Web Site. Accessed July 26, 2024. https://www.cms.gov/medicare/icd-10/2024-icd-10-cm.